StockDrifts LogoStockDrifts

Noile-Immune Biotech Inc. 4893

Company
ノイルイミューン・バイオテック株式会社Noile-Immune Biotech Inc.
Investors
8
Buys
8
Total Value
¥17.3B ($111.8M)
Avg Return
-76.97%
Last Filing
2024-07-31

Noile-Immune Biotech Inc. (4893) has 8 disclosed large-shareholding filings and 8 disclosed disposals on record, filed by 8 distinct investors. Together those filings cover ¥17.3B ($111.8M) in reported transaction value. The earliest filing StockDrifts holds for Noile-Immune Biotech Inc. is dated 2023-06-28; the most recent is 2024-07-31. Across these filings the average return since disclosure is -76.97%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

DateTypeSourceInsiderPurposeSharesPrice at filingReturnValue
2024-07-31SELLMarket Buy
株式会社鶴亀
TSURUKAME CO.,LTD
passive7.3M¥225+44.9%¥124M ($798K)
2024-07-31BUYMarket Buy
荻原 弘子
Hiroko Ogihara
passive1.0M¥225--
2024-07-31BUYMarket Buy
株式会社アプリコット
Apricot Co., Ltd.
passive680.3K¥225--
2024-07-26SELLMarket Buy
株式会社鶴亀
TSURUKAME CO.,LTD
passive7.8M¥229+45.9%¥321M ($2.1M)
2024-07-26BUYMarket Buy
株式会社アプリコット
Apricot Co., Ltd.
passive680.3K¥229--
2024-07-26BUYMarket Buy
荻原 弘子
Hiroko Ogihara
passive1.0M¥229--
2024-06-21SELLMarket Buy
株式会社鶴亀
TSURUKAME CO.,LTD
passive9.2M¥173+28.3%¥35M ($227K)
2024-06-21SELLMarket Buy
株式会社アプリコット
Apricot Co., Ltd.
passive680.3K¥173+28.3%¥91M ($585K)
2024-06-21BUYMarket Buy
荻原 弘子
Hiroko Ogihara
passive1.0M¥173--
2024-05-24SELLunknown
石﨑 秀信
Hidenobu Ishizaki
activist2.0M¥131+5.3%¥58M ($373K)
2024-03-06SELLMarket Buy
株式会社鶴亀
TSURUKAME CO.,LTD
passive9.4M¥187+33.7%¥87M ($564K)
2024-03-06BUYMarket Buy
株式会社アプリコット
Apricot Co., Ltd.
passive1.2M¥187--
2024-03-06BUYMarket Buy
荻原 弘子
Hiroko Ogihara
passive1.0M¥187--
2024-02-15BUYMarket Buy
荻原 弘子
Hiroko Ogihara
passive1.0M¥168--
2024-02-15SELLMarket Buy
株式会社鶴亀
TSURUKAME CO.,LTD
passive9.9M¥168+26.2%¥3M ($19K)
2024-02-15SELLMarket Buy
株式会社アプリコット
Apricot Co., Ltd.
passive1.2M¥168+26.2%¥727K ($5K)
2023-07-05BUYnegotiated
玉田 耕治
Koji Tamada
activist4.2M¥638-80.6%¥2.7B ($17.3M)
2023-07-05BUYunknown
武田薬品工業株式会社
Takeda Pharmaceutical Company, Limited
other8.1M¥638-80.6%¥5.2B ($33.4M)
2023-07-05BUYunknown
石﨑 秀信
Hidenobu Ishizaki
activist2.4M¥638-80.6%¥1.6B ($10.0M)
2023-07-05BUYMarket Buy
株式会社鶴亀
TSURUKAME CO.,LTD
passive9.9M¥638-80.6%¥6.3B ($40.6M)
2023-07-05BUYMarket Buy
荻原 弘子
Hiroko Ogihara
passive1.0M¥638-80.6%¥638M ($4.1M)
2023-07-05BUYMarket Buy
株式会社アプリコット
Apricot Co., Ltd.
passive1.2M¥638-80.6%¥768M ($5.0M)
2023-06-28BUYMarket Buy
株式会社バイジェン(BIGEN CO.
BIGEN CO., LTD.
passive933.3K¥715-82.7%¥667M ($4.3M)
2023-06-28BUYMarket Buy
株式会社バイネックス(BINEX CO.
BINEX CO., LTD.
passive2.3M¥715-82.7%¥1.6B ($10.5M)

Frequently asked questions

Who has been buying Noile-Immune Biotech Inc. stock?
8 distinct investors have filed 8 disclosed large-shareholding filings in Noile-Immune Biotech Inc. (4893), most recently on 2024-07-31. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Noile-Immune Biotech Inc. have?
Noile-Immune Biotech Inc. has 8 buy-side and 8 sell-side disclosures on record, covering ¥17.3B ($111.8M) in total reported value, spanning 2023-06-28 to 2024-07-31.
Do insider buys in Japanese stocks predict returns?
Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.